GlassScriptPhysician profile
Philip F Mckinney
NPI 1619047206
$3,774.90
in general payments reported to CMS, 2019-2025
16 companies · $54.20 in 2025
The $54.20 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $5.99 · 2021: $1,348 · 2022: $350 · 2023: $1,699 · 2024: $93.80 · 2025: $54.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148 · Travel and Lodging: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.58 |
| Travel and Lodging | $699.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,900.74 | 2021-2023 | |
| Relievant Medsystems, INC. | $148.89 | 2019 | |
| Grt US Holding, INC. | $130.04 | 2022 | |
| Medtronic, INC. | $97.41 | 2022 | |
| Amgen INC. | $93.80 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $85.41 | 2022 | |
| Abbvie INC. | $74.63 | 2019 | |
| Paragon 28, INC. | $69.16 | 2021 | |
| Heron Therapeutics, INC. | $38.33 | 2021-2025 | Zynrelef |
| Smith+Nephew, INC. | $35.57 | 2021-2025 | Grafix Pl |
| Stryker Corporation | $28.72 | 2023-2025 | Ortholoc 2 Lapifuse |
| Nevro Corp. | $23.82 | 2022 | |
| Convatec INC. | $14.82 | 2021 | |
| Organogenesis INC. | $13.92 | 2021 | |
| Bioventus LLC | $13.65 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $5.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Mckinney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.